Atherosclerosis
Volume 197, Issue 2 , Pages 496-503, April 2008

Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau

  • Gian Paolo Fadini

      Affiliations

    • Department of Clinical and Experimental Medicine, Metabolic Division, University of Padova, Medical School, Italy
    • Corresponding Author InformationCorresponding author at: Dipartimento di Medicina Clinica e Sperimentale, Malattie del Metabolismo, Policlinico Universitario, Via Giustiniani, 2, 35100 Padova, Italy. Tel.: +39 049 8212185; fax: +39 049 8212184.
  • ,
  • Ilenia Baesso

      Affiliations

    • Department of Clinical and Experimental Medicine, Clinical Immunology, University of Padova, Medical School, Italy
  • ,
  • Mattia Albiero

      Affiliations

    • Department of Biomedical Sciences, University of Padova, Medical School, Italy
  • ,
  • Saverio Sartore

      Affiliations

    • Department of Biomedical Sciences, University of Padova, Medical School, Italy
  • ,
  • Carlo Agostini

      Affiliations

    • Department of Clinical and Experimental Medicine, Clinical Immunology, University of Padova, Medical School, Italy
  • ,
  • Angelo Avogaro

      Affiliations

    • Department of Clinical and Experimental Medicine, Metabolic Division, University of Padova, Medical School, Italy

Received 26 September 2007; received in revised form 12 December 2007; accepted 24 December 2007. published online 13 February 2008.

Abstract 

In the last 10 years an increasing interest has been devoted to the study of endothelial progenitor cells (EPCs), a subtype of immature cells involved in endothelial repair and neoangiogenesis. EPCs have been discovered as a novel integrated part of the cardiovascular system, which plays a comprehensive role in tissue homeostasis. Consistently, alterations and/or reduction of the circulating EPC pool have been associated with different manifestations of cardiovascular disorders and atherosclerosis. This is why, the extent of the EPC pool is now considered a mirror of vascular health, while EPC reduction has become a surrogate biomarker of cardiovascular risk and of the ongoing vascular damage. Unfortunately, the methods used to study EPCs still lack standardization, and this is significantly decelerating progress in the field. In this review, we focus on some aspects related to the two methods used to assess circulating EPCs: flow cytometry and cell culture. We uncover the many traps hidden in the choice of the right protocol, and suggest the best solutions on the basis of evidence and background theories.

Keywords: Endothelial progenitor cells, Endothelium, Cell culture, Flow cytometry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(08)00012-9

doi:10.1016/j.atherosclerosis.2007.12.039

Atherosclerosis
Volume 197, Issue 2 , Pages 496-503, April 2008